Nanoscale small extracellular vesicles (sEVs, exosomes) in tears allow us to investigate the multisignatures of diseases. However, the translations of tear sEVs for biomarker discovery and clinical diagnostics are practically limited by low recovery, long processing time, and small sample volume. Here, we report an incorporated tear-exosomes analysis rapid-isolation system (iTEARS) nanotechnology to discover the secrets of ocular disorders and systemic diseases. We isolate exosomes rapidly with high yield and purity from a few teardrops (∼10 μL) within 5 min nanoporous membrane-based resonators for the quantitative detection and biomarker discovery through proteomic and transcriptomic analysis. We have identified 904 proteins, among which 228 proteins are discovered, 426 proteins are detected from exosomes of dry eye disease, and demonstrate CALML5, KRT6A, and S100P for the classification of dry eye disease. We have also investigated 484 miRNAs in tear exosomes and show miR-145-5p, miR-214-3p, miR-218-5p, and miR-9-5p are dysregulated during diabetic retinopathy development. We believe iTEARS can be used for improving molecular diagnostics tears to identify ocular disorders, systemic diseases, and numerous other neurodegenerative diseases and cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acsnano.2c02531 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in laboratory diagnosis of Sjogren's disease in children.
Clin Chim Acta
December 2024
Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing 100730, China. Electronic address:
Sjogren's disease (SjD) in children is a rare chronic autoimmune disease not fully recognized due to clinical manifestations different from adults. As such, new objective indicators are needed to supplement existing markers and assist in diagnosis. This review summarizes pathogenesis of SjD in children, current diagnostic criteria and research progress in laboratory diagnosis including serologic testing, saliva and tear analysis, histopathological examination as well as emerging markers of interest.
View Article and Find Full Text PDFMesenchymal stem cells and their exosomes mitigate osteoarthritis by restoring the balance between proinflammatory Teffs and Tregs.
Front Aging
November 2024
Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
Osteoarthritis (OA) is a degenerative joint disease caused by chronic inflammation that damages articular cartilage. In addition to the wear and tear of joints, aberrant remodelling driven by a significant presence of inflammatory mediators within the joint is one of the key mechanisms in the pathogenesis of OA. Among these factors, hyperactivation of Teffs subsets plays a crucial role in promoting this pathological process.
View Article and Find Full Text PDFEditorial Commentary: M2 Macrophage-Derived Exosomes Promote Tendon-to-Bone Healing by Alleviating Cellular Senescence in Aged Rats.
Arthroscopy
November 2024
Rochester, Minnesota.
Aging is associated with increased pathology in musculoskeletal tissues. Aging results in the accumulation of senescent cells, stem cell exhaustion, sterile inflammation, and immune cell dysfunction systemically and locally. Improving healing and regeneration during musculoskeletal aging is a significant area of clinical need.
View Article and Find Full Text PDFExosomes from Ameliorate Benzalkonium Chloride-Induced Inflammation in Conjunctival Cells.
Int J Mol Sci
November 2024
R&BD Center, Hy Co., Ltd., 22 Giheungdanji-ro 24 Beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea.
Article Synopsis
- Dry eye is a condition marked by low tear production and inflammation, which can lead to eye surface damage.
- Previous research identified HY7302 as a potential treatment, showing it can protect corneas in dry eye models by influencing gut microbiomes.
- In this study, HY7302-derived exosomes were found to lower genes for inflammation and increase tight junction proteins, suggesting they may help treat dry eye through interactions between the gut and eyes.
Multidimensional immunotherapy for dry eye disease: current status and future directions.
Front Ophthalmol (Lausanne)
November 2024
Department of Ophthalmology, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, China.
Dry Eye Disease (DED) is a multifactorial condition driven by tear film hyperosmolarity, immune dysregulation, and neuro-immune interactions. The immune system plays a central role in its pathogenesis, influencing both inflammation and ocular surface damage. While traditional immunotherapies like anti-inflammatory agents and immunosuppressants offer symptom relief, their long-term use is limited by side effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!